These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28718933)

  • 1. Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
    Mendes-Bastos P; Macedo R; Duarte R
    Br J Dermatol; 2017 Oct; 177(4):e150-e151. PubMed ID: 28718933
    [No Abstract]   [Full Text] [Related]  

  • 2. Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.
    Schneller-Pavelescu L; Vergara-de Caso E; Martorell A; Romaní J; Lázaro M; Vilarrasa E; Díaz-Ley B; Vázquez-Osorio I; Segura Palacios JM; Azaña JM; González-López MA; Cañueto J; Molina-Leyva A; Leiva-Salinas M; Navarro-Triviño FJ; Sánchez-Payá J; Pascual JC
    J Am Acad Dermatol; 2019 May; 80(5):1455-1457. PubMed ID: 30630028
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
    Delaunay J; Villani AP; Guillem P; Tristan A; Boibieux A; Jullien D
    Br J Dermatol; 2018 Jan; 178(1):e15-e16. PubMed ID: 28626900
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
    Albrecht J; Baine PA; Ladizinski B; Jemec GB; Bigby M
    Br J Dermatol; 2019 Apr; 180(4):749-755. PubMed ID: 30281779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile arising in a patient with hidradenitis suppurativa on clindamycin and rifampin.
    Bessaleli E; Scheinfeld N
    Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
    Bettoli V; Zauli S; Virgili A
    G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin and clindamycin for hidradenitis.
    Wall D; Kirby B
    J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
    [No Abstract]   [Full Text] [Related]  

  • 8. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
    J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
    Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
    Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
    Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
    Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
    van der Zee HH; Boer J; Prens EP; Jemec GB
    Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
    Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
    J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.
    Bettoli V; Zauli S; Borghi A; Toni G; Minghetti S; Ricci M; Virgili A
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):125-6. PubMed ID: 23451831
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
    Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
    Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
    Scheinfeld N
    Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
    Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
    J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
    Mendonça CO; Griffiths CE
    Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampin and clindamycin are safe long-term: Response to "North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management".
    Albrecht J; Bigby M
    J Am Acad Dermatol; 2023 Jan; 88(1):e31. PubMed ID: 31568806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.